IV Stroke Thrombolysis is a specialized clinical calculator and checklist tool for acute stroke management on iOS.
The App DNA
What makes this app unique?
It removes the cognitive friction of manual stroke scale calculations and guideline verification during high-pressure bedside assessments.
For Clinicians and medical professionals requiring bedside tools for acute stroke thrombolysis management.
What does it look like?
Key features
Includes NIH Stroke Scale, Dose Calculator, and Modified Rankin Scale for bedside assessment.
Step-by-step verification tool based on internationally accepted stroke guidelines.
Enables sharing of individual patient details via SMS or messaging platforms.
How much does it cost?
The app is distributed as a free utility with no visible monetization or subscription gates.
Velocity
Dormant developmentopaqueShow more...
The app has reached a zombie state, with no updates or feature releases in over 1,991 days. Development activity has been non-existent for several years, indicating the project is no longer being actively maintained or supported. There is no evidence of ongoing development or operational activity.
Who built it?
Mohan Noone
7 apps tracked · Medical
Courier Tracker »Pro«
Indian Train Status - minits
Indian Train Status - minits
Ticket-Wallet
Courier Tracker »Multi«
Divert CallsUser Sentiment
What do users think recently?
Recent user voice shows a thrilled sentiment. Users appreciate specialized medical tools like the stroke scale and dosing calculators provide high utility for clinical professionals.
How are ratings & reviews evolving?
What users say, by theme
- Specialized medical tools like the stroke scale and dosing calculators provide high utility for clinical professionals
3 of 3 recent reviews analyzed · limited sample
Read the full review analysisCompetition
Competitive landscape for IV Stroke Thrombolysis
How's the Medical market?
IV Stroke Thrombolysis occupies a niche segment of specialized medical utility apps, maintaining a 4.95 rating across its limited user base. Its lack of recent updates signals a static position in the medical category.
The rivals identified
The Analyst's Read
Key takeaways for IV Stroke Thrombolysis
Where is it heading?
The specialized medical utility market is shifting toward integrated, cloud-connected clinical decision support systems. IV Stroke Thrombolysis remains a stable, high-utility tool for its current audience, but its lack of updates leaves it vulnerable to obsolescence as clinical standards evolve.
- The five-year development gap suggests the app is in maintenance mode, which limits its ability to adapt to evolving stroke care standards.
The SWOT
- Clinical authority anchored to published trials
- Specialized bedside utility for stroke management
- Integration into broader telestroke workflows
- Update clinical guidelines to maintain relevance
Next best moves
Audit clinical guidelines because the app has not been updated since 2021 → ensure medical accuracy
The counter-intuitive read
The app's lack of updates is a feature, not a bug…
Read the full takeBottom line
The app provides high utility for its niche, but the five-year development gap threatens its long-term clinical reliability. A guideline audit would clarify whether the tool remains safe for current bedside practice.
Unlock 2 critical frictions, 2 market threats and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated